Clinical Trials in New York

Showing 3041-3060 of 10,830 trials

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT02744612

This phase II trial studies how well ibrutinib and brentuximab vedotin work in treating patients with Hodgkin lymphoma that has returned (relapsed) or does not respond to treatment (refractory). Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as brentuximab vedotin, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving ibrutinib together with brentuximab vedotin may be a better treatment for Hodgkin lymphoma.

Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma

City of Hope Medical Center39 participantsStarted Jun 2016

Duarte, California, United States • New York, New York, United States • Columbus, Ohio, United States

COMPLETEDNA< 1 mile

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

NCT03241459

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.

Peripheral Arterial DiseasePeripheral Vascular DiseaseArtery Disease, Peripheral+1 more

SurModics, Inc.446 participantsStarted Oct 2017

Birmingham, Alabama, United States • Foley, Alabama, United States • Gilbert, Arizona, United States +60 more locations

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Find Trials by Condition in New York

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

NOVOCART®3D for Treatment of Articular Cartilage of the Knee

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Oxytocin and Brain Responses in Maternal Addiction

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

A Prospective Observational Study of TPIAT

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

Effect of Fetal Aortic Valvuloplasty on Outcomes

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects